High Tide Inc
XTSX:HITI

Watchlist Manager
High Tide Inc Logo
High Tide Inc
XTSX:HITI
Watchlist
Price: 3.7 CAD -0.27% Market Closed
Market Cap: 298.5m CAD
Have any thoughts about
High Tide Inc?
Write Note

Relative Value

The Relative Value of one HITI stock under the Base Case scenario is 6.1 CAD. Compared to the current market price of 3.7 CAD, High Tide Inc is Undervalued by 39%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

HITI Relative Value
Base Case
6.1 CAD
Undervaluation 39%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
34
vs Industry
84
Median 3Y
0.4
Median 5Y
0.5
Industry
2.5
Forward
0.6
vs History
vs Industry
Median 3Y
-4.9
Median 5Y
-6.7
Industry
21.9
Forward
-365.3
vs History
31
vs Industry
44
Median 3Y
7.6
Median 5Y
6.9
Industry
16.5
vs History
15
vs Industry
22
Median 3Y
-6.6
Median 5Y
-6.6
Industry
23.6
vs History
44
vs Industry
46
Median 3Y
1.2
Median 5Y
1.9
Industry
2.1
vs History
42
vs Industry
85
Median 3Y
0.5
Median 5Y
0.5
Industry
2.6
Forward
0.6
vs History
38
vs Industry
73
Median 3Y
1.6
Median 5Y
1.8
Industry
5.2
vs History
52
vs Industry
43
Median 3Y
10.1
Median 5Y
7.8
Industry
13.3
Forward
7.9
vs History
20
vs Industry
16
Median 3Y
-9.1
Median 5Y
-9.1
Industry
16.6
Forward
43.2
vs History
44
vs Industry
43
Median 3Y
8.7
Median 5Y
8.1
Industry
15.6
vs History
23
vs Industry
31
Median 3Y
8.3
Median 5Y
-2.4
Industry
19.1
vs History
25
vs Industry
51
Median 3Y
1
Median 5Y
1.1
Industry
1.9

Multiples Across Competitors

HITI Competitors Multiples
High Tide Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
High Tide Inc
XTSX:HITI
297.6m CAD 0.6 -9.8 7.4 24.1
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
710.5B USD 17.4 84.9 45.7 51
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.3 27.8
US
Johnson & Johnson
NYSE:JNJ
373.5B USD 4.3 25.4 12.3 16
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
202.7B CHF 3.5 17.6 9.9 11.8
CH
Novartis AG
SIX:NOVN
183.3B CHF 4.1 11.6 10.1 14
UK
AstraZeneca PLC
LSE:AZN
162.4B GBP 4.1 31.6 169.4 253.9
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
CA
High Tide Inc
XTSX:HITI
Average P/E: 32.4
Negative Multiple: -9.8
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
84.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25.4
-22%
US
Merck & Co Inc
NYSE:MRK
20.7
7 321%
CH
Roche Holding AG
SIX:ROG
17.6
32%
CH
Novartis AG
SIX:NOVN
11.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.6
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top